Conference
Cctg MA.39 tailor RT: A randomized trial of regional radiotherapy in biomarker low-risk node-positive breast cancer (NCT03488693).
Abstract
TPS602
Background: Biomarker low risk, ER positive (+), HER2 negative (-) breast cancer with low burden nodal involvement may be associated with good outcomes (Woodward 2016, Mamounas 2017). There is conflicting data regarding the efficacy of regional radiotherapy after breast conserving surgery (BCS) or mastectomy in these patients (Kyndi 2008, Whelan 2015, Poortmans 2015, Liu 2015). Our hypothesis is that the risk of …
Authors
Parulekar WR; Berrang T; Kong I; Rakovitch E; Theberge V; Gelmon KA; Chia SKL; Bellon JR; Jagsi R; Ho AY
Volume
37
Pagination
pp. tps602-tps602
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2019
DOI
10.1200/jco.2019.37.15_suppl.tps602
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X